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Analysis of Graft Lamina Propria Associated Lymphocytes 
':;;;.",1,... a Recipient of a Human Cadaveric Small Bowel Allograft 
marily Immunosuppressed With FK 506 
.E. Uknis, K. Abu-Elmagd, S. Suwan, G. Block, D. Van Thiel, J. Reyes, A. Tzakis, A.J. Demetris, S. Todo, 
Starzl, R. Duquesnoy, and A. Zeevi 
SPLANT A TION of the intestine means trans-
-_plantation of viable donor lymphocytes into the re-
Therefore, in addition to rejection, there is the 
----, ... "". of graft-vs-host disease (GVHD). I More potent 
JmmUnO!lUp,pn:ssl:mt:s. such as FK 506, have made success-
clinical small bowel transplantation a reality. 2 With 
;imlnm'ved clinical outcomes3 it is valuable to assess the 
,functional capabilities of the lamina propria associated 
lymphocytes (LPAL). Our group has studied the LPAL 
, from serial intestinal graft biopsies taken from a recipient 
'who primarily receives FK 506 immunosuppression. 
patient is a 27-year-old woman Who, secondary to a 
,hypercoagulable state, thrombosed her mesenteric circu-
'lation resulting in necrosis of her small intestine. Liver 
failure was secondary to chronic total parenteral nutrition 
therapy. She received a liver/small intestine allograft from 
an ABO compatible donor. The patient was crossmatch 
"negative. The patient remained free of rejection until 
postoperative day (POD) 34. She was treated successfully 
and had a normal biopsy at POD 55. There were no 
episodes of GVHD. 
MATERIALS AND METHODS 
LP AL were propagated from serial proximal and distal mucosal 
biopsies by culturing divided biopsies for 2 weeks in RPMI 1640 
plus 5% human AD serum, and 30 U/mL recombinant interleu-
kin-2 (lL-2). Propagated LPAL from five serial biopsies of graft 
jejunum and ileum were tested for primed proliferative activity 
when challenged with irradiated donor splenocytes in a 3-day 
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Table 1. 
Primed Lymphocyte Testt 
eel-Mediatecl 
Background IL-2 Response Donor Spleen Cells Lympholysis t Histology 
370 ± 107 17.347 ± 513 22.141 :t 19.040 4% 
174 ± 47 12.342 ± 45 12.651 ± 8.881 9% 
177 ± 47 8273 ± 905 292:t 395 4% 
1.093 ± 669 14.937 ± 3.464 3.964 ± 1.165 0% 
65:!: 18 35.025 ± 2.779 16.097 :t 331 1% 
71 :t 59 27.457 ± 3.998 296± 40 4% 
Jejunum 264:t 66 14.409:!:1.119 17.260 ± 1.595 51% + 
POD 34 
Ileum 534 ± 191 26,846 ± 3.323 37.489 ± 5.201 13% + 
POD 34 
Jejunum 273 ± 257 4.751 ± 744 367 ± 50 0% 
POD 55 
Ileum 221 ± 208 1.771 ± 355 174:!: 67 0% 
POD 55 
tResuIts of the PL T are expressed in counlS per minute uptake of tritiated thymidine. 
*The eIecIcr 10 target cell ratio was 10:1 in al assays. PeroenIage values indicaIe (5'er experimental - spontaneous reINse)/(triton total - sporIaneoua reIeae) x 100. 
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assay. Proliferative activity was measured as uptake of tritiated 
thymidine. Additional LPAL were tested for cytotoxic activity 
against donor splenocyte targets labelled with 51Cr in a standard 
4-hour cell-mediated lympholysis assay. 
RESULTS 
Primed proliferative alloreactive T lymphocytes were 
propagated from four of eight biopsies that were declared 
histologically "normal" (Table 1). However, none of the 
eight normal biopsies yielded a population of T cells that 
were capable of killing donor targets (> 10% cytotoxicity). 
T lymphocytes propagated from biopsies taken during this 
patient's one episode of rejection (POD 34) yielded both 
primed proliferative and cytotoxic alloreactive T lympho-
cytes (Table 1). Follow-up biopsy at POD 55 (after solume-
drol therapy) yielded neither proliferative nor cytotoxic 
lymphocytes. 
CONCLUSIONS 
Propagation of T cells demonstrating primed proliferative 
responses to donor antigens occurred nonspecifically 
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throughout this patient's postoperative course_ These celIs 
likely represent a very small and adequately suppressed 
population of immunocompetent lymphocytes infiltrating 
the graft lamina propria. Their potential capabilities are 
suppressed by local endogenous factors and/or ther::.-·utic 
FK 506 concentrations. These cells lacked cytolytic ,apa.. 
bilities when the patient was free of rejection: however, 
when the patient rejected. donor-specific cytotoxic T cells 
were propagated. With improved clinical outcomes in 
human small intestine transplantation. more data can be 
accumulated to reveal the importance of the propagation of 
cytotoxic T cells from graft mucosal biopsies. 
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